1
Por Halicki, Priscila C. B., Ferreira, Laís A., De Moura, Kelly C. G., Carneiro, Paula F., Del Rio, Karina P., Carvalho, Tatiane dos S. C., Pinto, Maria do C. F. R., da Silva, Pedro E. A., Ramos, Daniela F.
Publicado no Front Microbiol (2018)
“... of resistant Mycobacterium tuberculosis strains. These barriers reinforcing the need for development of new...”Publicado no Front Microbiol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Zhang, Meijuan, Wang, Haiying, Zhao, Jinbing, Chen, Cong, Leak, Rehana K., Xu, Yun, Vosler, Peter, Gao, Yanqin, Zhang, Feng
Publicado em 2013
“... to induce therapeutic hypothermia have been established; however, most of them are not clinically feasible...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Artigo
3
“... them into drug-design and -discovery workflows while trying to answer a critical question: are QM-based...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Wesnes, Keith A.
Publicado em 2000
“...This paper reviews the value and utility of measuring cognitive function in the development of new...”Publicado em 2000
Obter o texto integral
Obter o texto integral
Artigo
5
Por A. E. Karateyev
Publicado em 2013-12-01
Assuntos:
“...nonsteroidal anti-inflammatory drugs...”Publicado em 2013-12-01
Obter o texto integral
Artigo
6
“... primarily attributed to their improved drug release controlling and targeting efficiencies. Also, the small...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Takenaka, Yukinori, Fukumori, Tomoharu, Yoshii, Tadashi, Oka, Natsuo, Inohara, Hidenori, Kim, Hyeong-Reh Choi, Bresalier, Robert S., Raz, Avraham
Publicado em 2004
Assuntos:
“...Cell Growth and Development...”Publicado em 2004
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Yildirim, Oktay, Gottwald, Matthias, Schüler, Peter, Michel, Martin C.
Publicado no Front Pharmacol (2016)
“...Drug development faces the double challenge of increasing costs and increasing pressure on pricing...”Publicado no Front Pharmacol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Mingote, Susana, Masson, Justine, Gellman, Celia, Thomsen, Gretchen M., Lin, Chyuan-Sheng, Merker, Robert J., Gaisler-Salomon, Inna, Wang, Yvonne, Ernst, Rachel, Hen, René, Rayport, Stephen
Publicado no Front Syst Neurosci (2016)
“...Genetic pharmacotherapy is an early drug development strategy for the identification of novel CNS...”Publicado no Front Syst Neurosci (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
“... are continuously being made across areas, but how does one optimally combine and focus them to maximize...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Song, Chull S., Moses, Harold L., Rosenthal, Alan S., Gelb, Nancy A., Kappas, Attallah
Publicado em 1971
“... inducers of hepatic ALAS does, however, develop in neonatal animals so that by approximately 5–6 wk of age...”Publicado em 1971
Obter o texto integral
Obter o texto integral
Artigo
12
“... to an antibiotic are also discussed. Lastly, the methods that have been developed for the identification...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Berry, Sarah L., Hameed, Hamza, Thomason, Anna, Maciej-Hulme, Marissa L., Saif Abou-Akkada, Somaia, Horrocks, Paul, Price, Helen P.
Publicado no PLoS Negl Trop Dis (2018)
“..., and resistance to them is emerging. New therapeutics are urgently needed, however, screening the infective...”Publicado no PLoS Negl Trop Dis (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Phansalkar, Shobha, Desai, Amrita A, Bell, Douglas, Yoshida, Eileen, Doole, John, Czochanski, Melissa, Middleton, Blackford, Bates, David W
Publicado em 2012
“...OBJECTIVE: To develop a set of high-severity, clinically significant drug–drug interactions (DDIs...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Hoffman, G S
Publicado em 2011
“... the disease, plus vulnerabilities of the patient that prepare them to develop an illness phenotype. Improved...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Blaine Stothard
Publicado em 2021-11-01
Assuntos:
“...drug policy and control...”Publicado em 2021-11-01
Obter o texto integral
Artigo
17
Por Csete, Joanne, Kamarulzaman, Adeeba, Kazatchkine, Michel, Altice, Frederick, Balicki, Marek, Buxton, Julia, Cepeda, Javier, Comfort, Megan, Goosby, Eric, Goulão, João, Hart, Carl, Horton, Richard, Kerr, Thomas, Lajous, Alejandro Madrazo, Lewis, Stephen, Martin, Natasha, Mejía, Daniel, Mathiesson, David, Obot, Isidore, Ogunrombi, Adeolu, Sherman, Susan, Stone, Jack, Vallath, Nandini, Vickerman, Peter, Zábranský, Tomáš, Beyrer, Chris
Publicado no Lancet (2016)
“... their health, human rights, and development impact. The Johns Hopkins – Lancet Commission on Drug Policy...”Publicado no Lancet (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
“...) may affect normal gene expression and disease progression, making them a new class of targets for drug...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Siemianowicz, Krzysztof, Likus, Wirginia, Dorecka, Mariola, Wilk, Renata, Dziubdziela, Włodzimierz, Markowski, Jarosław
Publicado no Biomed Res Int (2018)
“... technologies for provision of pharmaceutical forms of them, including drug nanocarriers, are currently underway...”Publicado no Biomed Res Int (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Krzysztof Siemianowicz, Wirginia Likus, Mariola Dorecka, Renata Wilk, Włodzimierz Dziubdziela, Jarosław Markowski
Publicado em 2018-01-01
“... technologies for provision of pharmaceutical forms of them, including drug nanocarriers, are currently underway...”Publicado em 2018-01-01
Obter o texto integral
Artigo